SJUTS DUSTIN S (Chief Commercial Officer) reported 1 transaction at REVANCE THERAPEUTICS, INC.
Review the transaction codes below to understand the nature of each event.
Filed: 12/18/2023ACC: 0001479290-23-000116
Officer· Chief Commercial Officer
Since Dec 2019
-4.71K
Net shares
Net seller
$38.1K
Total sold
0
Open market trades
0B · 0S
1
Total transactions
4.71K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−4.71K
Price / share
$8.08
Trade value
$38.07K
% of position
2.9%
12/15/2023
162.07K→157.35K
Total
Net shares
−4.71K
Net value
-$38.07K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 12/15/2023 | F · Tax Withholding | −4.71K | $8.08 | $38.07K | 2.9% | 162.07K | 157.35K |
| Total | −4.71K | -$38.07K | ||||||
Derivative Transactions0
No derivative transactions reported